Peng LF, Schaefer EAK, Maloof N, et al. Ceestatin, a novel small molecule inhibitor of hepatitis C virus replication, inhibits 3-hydroxy-3-methylglutaryl-coenzyme A synthase. J Infect Dis. 2011;204(4):609-16. doi:10.1093/infdis/jir303.
Peng LF, Kim SS, Matchacheep S, et al. Identification of novel epoxide inhibitors of hepatitis C virus replication using a high-throughput screen. Antimicrob Agents Chemother. 2007;51(10):3756-9. doi:10.1128/AAC.00233-07.
Kim SS, Peng LF, Lin W, et al. A cell-based, high-throughput screen for small molecule regulators of hepatitis C virus replication. Gastroenterology. 2007;132(1):311-20. doi:10.1053/j.gastro.2006.10.032.
Huang H, Duggal P, Thio CL, et al. Fine-mapping of genetic loci driving spontaneous clearance of hepatitis C virus infection. Sci Rep. 2017;7(1):15843. doi:10.1038/s41598-017-16011-2.
Lupberger J, Croonenborghs T, Suarez AAR, et al. Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease Development. Gastroenterology. 2019;157(2):537-551.e9. doi:10.1053/j.gastro.2019.04.003.
Kuntzen T, Timm J, Berical A, et al. Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients. Hepatology. 2008;48(6):1769-78. doi:10.1002/hep.22549.
Kuntzen T, Berical A, Ndjomou J, et al. A set of reference sequences for the hepatitis C genotypes 4d, 4f, and 4k covering the full open reading frame. J Med Virol. 2008;80(8):1370-8. doi:10.1002/jmv.21240.
Oniangue-Ndza C, Kuntzen T, Kemper M, et al. Compensatory mutations restore the replication defects caused by cytotoxic T lymphocyte escape mutations in hepatitis C virus polymerase. J Virol. 2011;85(22):11883-90. doi:10.1128/JVI.00779-11.
March S, Ramanan V, Trehan K, et al. Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens. Nat Protoc. 2015;10(12):2027-53. doi:10.1038/nprot.2015.128.